Found 210 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query: gtpase kras

Total Genus Sequence Length pdb Title
64 170 7a1xA Krasg12c gdp form in complex with cpd1
66 169 7a1yA Krasg12c gdp form in complex with cpd2
67 183 7rseA Nmr-driven structure of the kras4b-g12d "alpha-beta" dimer on a lipid bilayer nanodisc
83 187 7rscD Nmr-driven structure of the kras4b-g12d "alpha-alpha" dimer on a lipid bilayer nanodisc
62 183 7rscA Nmr-driven structure of the kras4b-g12d "alpha-alpha" dimer on a lipid bilayer nanodisc
83 187 7rseD Nmr-driven structure of the kras4b-g12d "alpha-beta" dimer on a lipid bilayer nanodisc
58 169 7lgiA The haddock model of gdp kras in complex with promazine using chemical shift perturbations and intermolecular noes
19 81 7lc2D Crystal structure of kras4b-q61r (gmppnp-bound) in complex with the ras-binding domain (rbd) of sin1
46 167 7lc2A Crystal structure of kras4b-q61r (gmppnp-bound) in complex with the ras-binding domain (rbd) of sin1
18 91 7ny8C Affimer k69 - kras protein complex
65 168 7ny8A Affimer k69 - kras protein complex
61 168 7c41A Kras g12v and h-rev107 peptide complex
0 10 7c41D Kras g12v and h-rev107 peptide complex
58 168 7c40A Mggdp bound kras g12v
52 168 7kfzA Structure of a ternary kras(g13d)-sos complex
142 479 7kfzB Structure of a ternary kras(g13d)-sos complex
56 168 6vc8A Crystal structure of wild-type kras4b(1-169) in complex with gmppnp and mg ion
61 167 7acqA Crystal structure of inactive kras g12d (gdp) in complex with the soaked dimeric inhibitor bi-5747
62 169 7acfA Crystal structure of crystal form 2 of an active kras g12d (gppcp) dimer in complex with bi-5747
58 167 7achA Crystal structure of active kras g12d (gppcp) in complex with the soaked dimeric inhibitor bi-5747
62 167 7acaA Crystal structure of an active kras g12d (gppcp) dimer in complex with bi-5747
54 168 6xguA Crystal structure of kras-q61r (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf
24 134 6xguB Crystal structure of kras-q61r (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf
69 168 6vjjA Crystal structure of wild-type kras4b (gmppnp-bound) in complex with ras-binding domain (rbd) of raf1/craf
66 169 6xi7A Crystal structure of wild-type kras (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf (crystal form i)
17 77 6vjjB Crystal structure of wild-type kras4b (gmppnp-bound) in complex with ras-binding domain (rbd) of raf1/craf
24 130 6xi7B Crystal structure of wild-type kras (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf (crystal form i)
23 134 6xgvB Crystal structure of kras-g13d (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf
64 168 6xgvA Crystal structure of kras-g13d (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf
23 134 6xhbB Crystal structure of wild-type kras (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf (crystal form ii)
59 168 6xhbA Crystal structure of wild-type kras (gmppnp-bound) in complex with ras-binding domain (rbd) and cysteine-rich domain (crd) of raf1/craf (crystal form ii)
0 15 6wgnE Crystal structure of k-ras(g12d) gppnhp bound to cyclic peptide ligand kd2
64 169 6wgnA Crystal structure of k-ras(g12d) gppnhp bound to cyclic peptide ligand kd2
58 167 6zliA Crystal structure of kras-g12d in complex with compound 13 and gcp
61 168 6zl5A Crystal structure of kras-g12d(c118s) in complex with bi-2852 and gdp
14 89 6yxwB Affimer k3 - kras protein complex
65 166 6yxwA Affimer k3 - kras protein complex
16 89 6yr8B Affimer k6 - kras protein complex
60 168 6yr8A Affimer k6 - kras protein complex
62 177 6pq3A Crystal structure of gdp-bound kras with ten residues long internal tandem duplication in the switch ii region
61 167 6usxA Identification of the clinical development candidate mrtx849, a covalent krasg12c inhibitor for the treatment of cancer
67 169 6uszA Identification of the clinical development candidate mrtx849, a covalent krasg12c inhibitor for the treatment of cancer
57 169 6ut0A Identification of the clinical development candidate mrtx849, a covalent krasg12c inhibitor for the treatment of cancer
58 168 6mtaA Kras mutant structure in complex with gtp analogue
62 168 6ms9A Gdp-bound kras switch 1 mutant
60 169 6mnxA Structural basis of impaired hydrolysis in kras mutant
66 170 6tamA X-ray structure of human k-ras g12c in complex with covalent isoquinolinone inhibitor (compound 3)
61 170 6tanA X-ray structure of human k-ras g12c in complex with covalent isoquinolinone inhibitor (compound 17)
62 169 6o46A Crystal structure of human kras mutant in complex with gnp and phosphate
62 170 6t5bA Krasg12c ligand complex